Because many oncogenes in human breast cancer upregulate PI3K signaling, and PI3K somatic mutation was frequently detected in human breast cancers, this pathway could realistically account for the high intracellular NIS expression and lack of radioiodide uptake in most human breast cancers. Here, PIK3CA is linked to breast carcinoma.